New VLA-4 antagonist designed at Celltech is a potent, orally active antiasthmatic agent May 11, 2000
Inhibition of allergen-induced increases in exhaled NO and airways hyperresponsiveness with SD-3651 May 10, 2000
New Abbott compound at least as effective as ciclosporin, prednisolone in acute primate asthma model May 9, 2000
RSS